54325 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Jul 01
00:57 UTC
|
ZIM
ZIM Integrated Shipping Services
|
◎ Target | Alexia Dogani not yet tracked | Underweight | $9.00→ $16.50+83.3% |
|
Jul 01
00:57 UTC
|
ZGN
Ermenegildo Zegna
|
◎ Target | Chiara Battistini not yet tracked | Overweight | $12.50→ $14.00+12.0% |
|
Jul 01
00:57 UTC
|
WPM
Wheaton Precious Metals
|
◎ Target | Daniel Major ★★★☆☆ #1818 | Buy | $165.00→ $150.00-9.1% |
|
Jul 01
00:57 UTC
|
WLK
Westlake
|
◎ Target | Matthew DeYoe ★★★☆☆ #1432 | Neutral | $104.00→ $85.00-18.3% |
|
Jul 01
00:57 UTC
|
VRDN
Viridian Therapeutics
|
◎ Target | Laura Chico ★★★☆☆ #2194 | Outperform | $32.00→ $43.00+34.4% |
|
Jul 01
00:57 UTC
|
VRDN
Viridian Therapeutics
|
◎ Target | Gregory Renza ★★★☆☆ #1071 | Buy | $35.00→ $38.00+8.6% |
|
Jul 01
00:57 UTC
|
VRDN
Viridian Therapeutics
|
◎ Target | Lisa Walter ★★☆☆☆ #2461 | Outperform | $34.00→ $35.00+2.9% |
|
Jul 01
00:57 UTC
|
VMC
Vulcan Materials
|
◎ Target | Anthony Codling ★★★☆☆ #1260 | Sec→ r Perform | $298.00→ $293.00-1.7% |
|
Jul 01
00:57 UTC
|
VIRT
Virtu Financial
|
◎ Target | Alexander Blostein ★★★★☆ #480 | Neutral | $51.00→ $63.00+23.5% |
|
Jul 01
00:57 UTC
|
VAC
Marriott Vacations Worldwide
|
◎ Target | Chris Woronka ★★★★☆ #443 | Buy | $92.00→ $119.00+29.3% |
|
Jul 01
00:57 UTC
|
USB
U.S. Bancorp
|
◎ Target | Chris Kotowski ★★★★☆ #644 | Outperform | $74.00→ $73.00-1.4% |
|
Jul 01
00:57 UTC
|
UNH
UnitedHealth Group
|
◎ Target | Erin Wright ★★★★★ #309 | Overweight | $453.00→ $468.00+3.3% |
|
Jul 01
00:57 UTC
|
UNCY
Unicycive Therapeutics
|
◎ Target | Swayampakula Ramakanth ★★☆☆☆ #2757 | Buy | $22.00→ $15.00-31.8% |
|
Jul 01
00:57 UTC
|
UGP
Ultrapar Participacoes
|
◎ Target | Leonardo Marcondes ★★★★☆ #529 | Neutral | $6.30→ $6.80+7.9% |
|
Jul 01
00:57 UTC
|
UAL
United Airlines
|
◎ Target | Christian Wetherbee ★★★☆☆ #1133 | Overweight | $130.00→ $165.00+26.9% |
|
Jul 01
00:57 UTC
|
TTI
Tetra Technologies
|
◎ Target | Bobby Brooks ★★★☆☆ #2190 | Outperform | $11.50→ $14.00+21.7% |
|
Jul 01
00:57 UTC
|
TSHA
Taysha Gene Therapies
|
◎ Target | Jack Allen ★★★☆☆ #2232 | Outperform | $12.00→ $15.00+25.0% |
|
Jul 01
00:57 UTC
|
TROW
T. Rowe Price Group
|
◎ Target | Alexander Blostein ★★★★☆ #480 | Sell | $90.00→ $92.00+2.2% |
|
Jul 01
00:57 UTC
|
TFII
TFI International
|
◎ Target | Kevin Chiang ★★★★★ #295 | Outperform→ Outperformer | $162.00→ $172.00+6.2% |
|
Jul 01
00:57 UTC
|
TER
Teradyne
|
◎ Target | Mehdi Hosseini ★★★☆☆ #2032 | Positive | $415.00→ $550.00+32.5% |
|
Jul 01
00:57 UTC
|
TENB
Tenable
|
◎ Target | Brian Essex ★★★☆☆ #1378 | Overweight | $35.00→ $40.00+14.3% |
|
Jul 01
00:57 UTC
|
SUI
Sun Communities
|
◎ Target | Haendel St. not yet tracked | Outperform | $143.00→ $137.00-4.2% |
|
Jul 01
00:57 UTC
|
STT
State Street
|
◎ Target | Alexander Blostein ★★★★☆ #480 | Buy | $168.00→ $194.00+15.5% |
|
Jul 01
00:57 UTC
|
SSRM
Silver Standard Resources
|
◎ Target | George Eadie ★★☆☆☆ #2471 | Buy | $43.00→ $40.00-7.0% |
|
Jul 01
00:57 UTC
|
SOLS
Solstice Advanced Mat
|
◎ Target | Arun Viswanathan ★★★☆☆ #1405 | Outperform | $100.00→ $102.00+2.0% |
|
Jul 01
00:57 UTC
|
RXO
RXO
|
◎ Target | Thomas Wadewitz ★★★☆☆ #1955 | Neutral | $22.00→ $26.00+18.2% |
|
Jul 01
00:57 UTC
|
RVMD
Revolution Medicines
|
◎ Target | Gregory Renza ★★★☆☆ #1071 | Buy | $179.00→ $210.00+17.3% |
|
Jul 01
00:57 UTC
|
RUS
Russel Metals
|
◎ Target | firm only | Outperform | C$63.00→ C$68.00+7.9% |
|
Jul 01
00:57 UTC
|
RRC
Range Resources
|
◎ Target | Umang Choudhary not yet tracked | Neutral | $44.00→ $39.00-11.4% |
|
Jul 01
00:57 UTC
|
RKLB
Rocket Lab
|
◎ Target | Trevor Walsh not yet tracked | Market Outperform | $95.00→ $130.00+36.8% |
|
Jul 01
00:57 UTC
|
RKLB
Rocket Lab
|
◎ Target | Ronald Epstein ★★☆☆☆ #2473 | Buy | $105.00→ $115.00+9.5% |
|
Jul 01
00:57 UTC
|
RGLD
Royal Gold
|
◎ Target | Daniel Major ★★★☆☆ #1818 | Buy | $325.00→ $280.00-13.8% |
|
Jul 01
00:57 UTC
|
REPL
Replimune Group
|
◎ Target | Robert Driscoll ★★☆☆☆ #2375 | Neutral | $6.00→ $9.00+50.0% |
|
Jul 01
00:57 UTC
|
RBLX
Roblox
|
◎ Target | Ken Gawrelski ★★★☆☆ #1155 | Overweight | $55.00→ $56.00+1.8% |
|
Jul 01
00:57 UTC
|
PNC
The PNC Financial Services Group
|
◎ Target | Chris Kotowski ★★★★☆ #644 | Outperform | $268.00→ $271.00+1.1% |
|
Jul 01
00:57 UTC
|
PNC
The PNC Financial Services Group
|
◎ Target | Benjamin Gerlinger not yet tracked | Buy | $255.00→ $280.00+9.8% |
|
Jul 01
00:57 UTC
|
PGR
Progressive
|
◎ Target | Brian Meredith ★★★★★ #150 | Neutral | $220.00→ $230.00+4.5% |
|
Jul 01
00:57 UTC
|
PAYX
Paychex
|
◎ Target | James Faucette ★★★☆☆ #1191 | Equal Weight | $107.00→ $109.00+1.9% |
|
Jul 01
00:57 UTC
|
PANW
Palo Alto Networks
|
◎ Target | Gray Powell ★★★★★ #19 | Buy | $333.00→ $380.00+14.1% |
|
Jul 01
00:57 UTC
|
OXY
Occidental Petroleum
|
◎ Target | firm only | Neutral | $64.00→ $60.00-6.2% |
|
Jul 01
00:57 UTC
|
OC
Owens Corning
|
◎ Target | Collin Verron ★★★☆☆ #1849 | Buy | $136.00→ $165.00+21.3% |
|
Jul 01
00:57 UTC
|
NXRT
NexPoint Residential Trust
|
◎ Target | Michael Lewis ★★★★☆ #834 | Hold | $27.00→ $26.00-3.7% |
|
Jul 01
00:57 UTC
|
NTRS
Northern Trust
|
◎ Target | Benjamin Gerlinger not yet tracked | Neutral | $162.00→ $172.00+6.2% |
|
Jul 01
00:57 UTC
|
NESR
National Energy Services Reunited
|
◎ Target | Josh Silverstein ★★☆☆☆ #2374 | Buy | $32.00→ $36.00+12.5% |
|
Jul 01
00:57 UTC
|
NEO
Neo Performance Materials
|
◎ Target | firm only | Outperform | C$37.50→ C$43.00+14.7% |
|
Jul 01
00:57 UTC
|
NEM
Newmont
|
◎ Target | firm only | Outperform | $139.00→ $137.00-1.4% |
|
Jul 01
00:57 UTC
|
NEM
Newmont
|
◎ Target | Daniel Major ★★★☆☆ #1818 | Buy | $140.00→ $120.00-14.3% |
|
Jul 01
00:57 UTC
|
NE
Noble
|
◎ Target | Scott Gruber ★★☆☆☆ #2688 | Neutral | $52.00→ $45.00-13.5% |
|
Jul 01
00:57 UTC
|
NAMS
NewAmsterdam Pharma
|
◎ Target | Leonid Timashev ★★★☆☆ #1208 | Outperform | $47.00→ $51.00+8.5% |
|
Jul 01
00:57 UTC
|
MYE
Myers Industries
|
◎ Target | Steve Barger ★★☆☆☆ #2408 | Overweight | $37.00 |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.